loadpatents
name:-0.032351016998291
name:-0.034106969833374
name:-0.0038161277770996
EZRIN; Alan M. Patent Filings

EZRIN; Alan M.

Patent Applications and Registrations

Patent applications and USPTO patent grants for EZRIN; Alan M..The latest application filed is for "elution of microparticles by size exclusion chromatography using water as a mobile phase".

Company Profile
3.27.43
  • EZRIN; Alan M. - Miami FL
  • Ezrin; Alan M. - Vancouver CA
  • Ezrin; Alan M - Miami FL
  • Ezrin; Alan M. - Moraga CA
  • Ezrin; Alan M. - Moraga Town CA
  • Ezrin; Alan M. - Colonie NY
*profile and listings may contain filings by different individuals or companies with the same name. Review application materials to confirm ownership/assignment.
Patent Activity
PatentDate
Elution Of Microparticles By Size Exclusion Chromatography Using Water As A Mobile Phase
App 20220236277 - EZRIN; Alan M.
2022-07-28
5-ALA for detection of brain tumors
Grant 11,307,204 - Ezrin April 19, 2
2022-04-19
Use Of Circulating Microparticles To Stratify Risk Of Spontaneous Preterm Birth
App 20210270840 - BROHMAN; Brian D. ;   et al.
2021-09-02
Treatment Of Spontaneous Preterm Birth
App 20210231674 - EZRIN; Alan M. ;   et al.
2021-07-29
Treatment of spontaneous preterm birth
Grant 10,928,402 - Ezrin , et al. February 23, 2
2021-02-23
Treatment of spontaneous preterm birth
Grant 10,877,046 - Brohman , et al. December 29, 2
2020-12-29
5-ala For Detection Of Brain Tumors
App 20200124607 - EZRIN; Alan M.
2020-04-23
Use Of Circulating Microparticles To Stratify Risk Of Spontaneous Preterm Birth
App 20190041391 - BROHMAN; Brian D. ;   et al.
2019-02-07
5-ala For Detection Of Brain Tumors
App 20170192005 - EZRIN; Alan M.
2017-07-06
5-ALA for detection of brain tumors
Grant 9,493,810 - Ezrin November 15, 2
2016-11-15
5-ala For Detection Of Brain Tumors
App 20160326566 - EZRIN; Alan M.
2016-11-10
Use Of Tenascin-c As An Extracellular Marker Of Tumor-derived Microparticles
App 20160097771 - EZRIN; Alan M. ;   et al.
2016-04-07
Microvesicle Histone H2ax As A Biomarker For Genotoxic Stress
App 20160041175 - EZRIN; Alan M.
2016-02-11
Biomarkers Of Preterm Birth
App 20150355188 - EZRIN; Alan M. ;   et al.
2015-12-10
Biomarkers Of Preterm Birth
App 20140186332 - EZRIN; Alan M. ;   et al.
2014-07-03
5-ala For Detection Of Brain Tumors
App 20130330753 - EZRIN; Alan M.
2013-12-12
Ion channel modulating activity I
Grant 8,207,219 - Fedida , et al. June 26, 2
2012-06-26
Uses of ion channel modulating compounds
Grant 8,188,140 - Beatch , et al. May 29, 2
2012-05-29
Ion Channel Modulating Activity Ii
App 20120095073 - Fedida; David ;   et al.
2012-04-19
Uses Of Ion Channel Modulating Compounds
App 20110118329 - Beatch; Gregory N. ;   et al.
2011-05-19
Pegylated Ion Channel Modulating Compounds
App 20100273724 - Cheu; Elizabeth L. S. ;   et al.
2010-10-28
Uses of ion channel modulating compounds
Grant 7,820,712 - Beatch , et al. October 26, 2
2010-10-26
Drug conjugates of ion channel modulating compounds
Grant 7,786,119 - Cheu , et al. August 31, 2
2010-08-31
Ion Channel Modulating Activity I
App 20100120890 - Fedida; David ;   et al.
2010-05-13
Ion channel modulating activity I
Grant 7,674,820 - Fedida , et al. March 9, 2
2010-03-09
Ion Channel Modulating Activity Ii
App 20090270478 - Fedida; David ;   et al.
2009-10-29
Modified therapeutic peptides with extended half-lives in vivo
App 20090175821 - Bridon; Dominique P. ;   et al.
2009-07-09
Ion channel modulating activity method
Grant 7,507,545 - Fedida , et al. March 24, 2
2009-03-24
Controlled Release Tablet Formulations For The Prevention Of Arrhythmias
App 20090041841 - Beatch; Gregory N. ;   et al.
2009-02-12
Uses Of Ion Channel Modulating Compounds
App 20080188547 - Beatch; Gregory N. ;   et al.
2008-08-07
Uses of ion channel modulating compounds
Grant 7,345,086 - Beatch , et al. March 18, 2
2008-03-18
Controlled Release Tablet Formulations For The Prevention Of Arrhythmias
App 20080063707 - Beatch; Gregory N. ;   et al.
2008-03-13
Pegylated Ion Channel Modulating Compounds
App 20080021005 - Cheu; Elizabeth L.S. ;   et al.
2008-01-24
Protection of endogenous therapeutic peptides from peptidase activity through conjugation to blood components
Grant 7,256,253 - Bridon , et al. August 14, 2
2007-08-14
Ion channel modulating activity II
App 20060199848 - Fedida; David ;   et al.
2006-09-07
Ion channel modulating activity I
App 20060135536 - Fedida; David ;   et al.
2006-06-22
Long lasting synthetic glucagon like peptide (GLP-1)
App 20060135426 - Bridon; Dominique P. ;   et al.
2006-06-22
Long lasting synthetic glucagon like peptide (GLP-1)
App 20060058235 - Bridon; Dominique P. ;   et al.
2006-03-16
Long lasting synthetic glucagon like peptide (GLP-1)
App 20060009377 - Bridon; Dominique P. ;   et al.
2006-01-12
Protection of endogenous therapeutic peptides from peptidase activity through conjugation to blood components
App 20050187159 - Bridon, Dominique P. ;   et al.
2005-08-25
Ion channel modulating activity II
App 20050119315 - Fedida, David ;   et al.
2005-06-02
Long lasting synthetic glucagon-like peptide {GLP-1}
Grant 6,887,849 - Bridon , et al. May 3, 2
2005-05-03
Protection of endogenous therapeutic peptides from peptidase activity through conjugation to blood components
Grant 6,887,470 - Bridon , et al. May 3, 2
2005-05-03
Ion channel modulating activity I
App 20050070552 - Fedida, David ;   et al.
2005-03-31
Uses of ion channel modulating compounds
App 20050026993 - Beatch, Gregory N. ;   et al.
2005-02-03
Protection of endogenous therapeutic peptides from peptidase activity through conjugation to blood components
Grant 6,849,714 - Bridon , et al. February 1, 2
2005-02-01
Long lasting synthetic glucagon-like peptide (GLP-1)
Grant 6,821,949 - Bridon , et al. November 23, 2
2004-11-23
Pulmonary delivery for bioconjugation
App 20040156859 - Ezrin, Alan M. ;   et al.
2004-08-12
Long lasting synthetic glucagon like peptide (GLP-1)
App 20040138100 - Bridon, Dominique ;   et al.
2004-07-15
Long lasting synthetic glucagon like peptide (GLP-1)
App 20040127398 - Bridon, Dominique P. ;   et al.
2004-07-01
Pulmonary delivery for bioconjugation
Grant 6,706,892 - Ezrin , et al. March 16, 2
2004-03-16
Local delivery of long lasting therapeutic agents
App 20030170250 - Ezrin, Alan M. ;   et al.
2003-09-11
Method for alleviating pain or providing an analgesic effect in a patient
Grant 6,610,825 - Ezrin , et al. August 26, 2
2003-08-26
Antinociceptive agent derivative
Grant 6,602,981 - Ezrin , et al. August 5, 2
2003-08-05
Long lasting insulinotropic peptides
Grant 6,593,295 - Bridon , et al. July 15, 2
2003-07-15
Long lasting synthetic glucagon-like peptide {GLP-1}
App 20030108567 - Bridon, Dominique P. ;   et al.
2003-06-12
Long lasting synthetic glucagon-like peptide {GLP-1}
App 20030108568 - Bridon, Dominique P. ;   et al.
2003-06-12
Long lasting synthetic glucagon like peptide {GLP-!}
Grant 6,514,500 - Bridon , et al. February 4, 2
2003-02-04
Conjugate comprising an antinociceptive agent covalently bonded to a blood component
Grant 6,500,918 - Ezrin , et al. December 31, 2
2002-12-31
Long lasting insulinoptropic peptides
App 20020049153 - Bridon, Dominique P. ;   et al.
2002-04-25
Antinociceptive agent derivative
App 20020039999 - Ezrin, Alan M. ;   et al.
2002-04-04
Cellular And Serum Protein Anchors For Diagnostic Imaging
App 20020018751 - BRIDON, DOMINIQUE P. ;   et al.
2002-02-14
Long lasting insulinotropic peptides
Grant 6,329,336 - Bridon , et al. December 11, 2
2001-12-11
Method for alleviating pain or providing an analgesic effect in a patient
App 20010018420 - Ezrin, Alan M. ;   et al.
2001-08-30
Conjugate comprising an antinociceptive agent covalently bonded to a blood component
App 20010018421 - Ezrin, Alan M. ;   et al.
2001-08-30
Methods and compositions for producing novel conjugates of thrombin inhibitors and endogenous carriers resulting in anti-thrombins with extended lifetimes
Grant 6,277,863 - Krantz , et al. August 21, 2
2001-08-21
Methods for producing novel conjugates of thrombin inhibitors
Grant 5,942,620 - Krantz , et al. August 24, 1
1999-08-24
Methods and compositions for producing novel conjugates of thrombin inhibitors and endogenous carriers resulting in anti-thrombins with extended lifetimes
Grant 5,840,733 - Krantz , et al. November 24, 1
1998-11-24
Aryl-fused and hetaryl-fused-2,4-diazepine and 2,4-diazocine antiarrhythmic agents
Grant 5,624,922 - Johnson , et al. April 29, 1
1997-04-29

uspto.report is an independent third-party trademark research tool that is not affiliated, endorsed, or sponsored by the United States Patent and Trademark Office (USPTO) or any other governmental organization. The information provided by uspto.report is based on publicly available data at the time of writing and is intended for informational purposes only.

While we strive to provide accurate and up-to-date information, we do not guarantee the accuracy, completeness, reliability, or suitability of the information displayed on this site. The use of this site is at your own risk. Any reliance you place on such information is therefore strictly at your own risk.

All official trademark data, including owner information, should be verified by visiting the official USPTO website at www.uspto.gov. This site is not intended to replace professional legal advice and should not be used as a substitute for consulting with a legal professional who is knowledgeable about trademark law.

© 2024 USPTO.report | Privacy Policy | Resources | RSS Feed of Trademarks | Trademark Filings Twitter Feed